Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Adaptimmune
Adaptimmune
Activities:
Pharmaceutical
Cell & Gene Therapy
X
LinkedIn
Trending Articles
OINDPs: Nosey about recent developments?
OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
Transforming healthcare with patient centricity
In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Compact process thermostat for efficient temperature control in the laboratory
The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
AviadoBio expands presence at Canary Wharf
The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Design & Build
Cell and Gene Therapy Catapult opens manufacturing centre
More than £60 million of UK government investment is being used to develop the new centre, which aims to accelerate growth of the industry in the UK
Research & Development
Adaptimmune announces commercial development and supply agreement with Thermo Fisher Scientific
Agreement enhances existing Dynabeads CD3/CD28 cell therapy system business
Design & Build
Adaptimmune announces new research and development facility
The flagship facility will provide laboratory space with associated offices and meeting rooms
Research & Development
Adaptimmune expands Senior Clinical Management team
Lini Pandite and Anne-Marie Martin join the Clinical Development and Biomarker R&D teams
Subscribe now